In the small world of big CEOs, the perks can be spectacular.

Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa, which could become the first new prescription drug to reach the market in more than a decade.

A Delaware judge has given Google Inc. until April 9 to give a pension fund investors company documents involving what authorities said was the illegal online marketing of prescription drugs to U.S. consumers by Canadian pharmacies.

WellPoint Inc.'s fourth-quarter earnings sank 39 percent as medical claims soared thanks to a $50 million hit from the health insurer's Medicare Advantage business, but the company forecast earnings growth in 2012.

Just as the U.S. economy is making progress despite Europe's turmoil, here come two new threats.

Signs of growth in the U.S. economy combined with an unexpected interest rate cut in Europe to send the Dow Jones industrial average up more than 100 points for the second day in a row.

Small businesses are toning down their holiday celebrations and gifts again.

Stock indexes rose Wednesday after a steep two-day drop as international leaders scrambled to save a week-old plan to prevent a financial crisis in Europe. Strong corporate earnings and a bump up in hiring by private companies also helped turn markets around.